Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AgeX Therapeutics Inc (AGE)
NYSE MKT:AGE
Holding AGE?
Track your performance easily
AGE Stock Chart & Stats
Day’s Range$11.1 - $12.59
52-Week Range― - ―
Previous Close$12.6
Volume3.75K
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
May 15, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
AgeX Therapeutics News
PremiumCompany Announcements
AgeX Therapeutics Secures Funding, Details in SEC Report
PremiumCompany Announcements
AgeX Therapeutics Postpones Merger Completion with Serina
PremiumCompany Announcements
AgeX Therapeutics Expands Ties with JuvVentures Equity Deal
PremiumCompany Announcements
AgeX Therapeutics Secures $500K Convertible Note DealRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AGE FAQ
What was AgeX Therapeutics Inc’s price range in the past 12 months?
Currently, no data Available
What is AgeX Therapeutics Inc’s market cap?
Currently, no data Available
When is AgeX Therapeutics Inc’s upcoming earnings report date?
AgeX Therapeutics Inc’s upcoming earnings report date is May 15, 2024 which is 221 days ago.
How were AgeX Therapeutics Inc’s earnings last quarter?
AgeX Therapeutics Inc released its earnings results on Mar 22, 2024. The company reported -$3.203 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.203.
Is AgeX Therapeutics Inc overvalued?
According to Wall Street analysts AgeX Therapeutics Inc’s price is currently Overvalued.
Does AgeX Therapeutics Inc pay dividends?
AgeX Therapeutics Inc does not currently pay dividends.
What is AgeX Therapeutics Inc’s EPS estimate?
AgeX Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AgeX Therapeutics Inc have?
Currently, no data Available
What happened to AgeX Therapeutics Inc’s price movement after its last earnings report?
AgeX Therapeutics Inc reported an EPS of -$3.203 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.3%.
Which hedge fund is a major shareholder of AgeX Therapeutics Inc?
Among the largest hedge funds holding AgeX Therapeutics Inc’s share is Defender Capital, LLC.. It holds AgeX Therapeutics Inc’s shares valued at N/A.
---
AgeX Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
AgeX Therapeutics Inc
AgeX Therapeutics, Inc. operates as a biotechnology company. It focuses on the development and commercialization of novel therapeutics targeting human aging. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.
---
Technical Analysis
---